Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; the references it cites are not checked yet.

Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer’s Disease

Abstract

Finding an effective cure for Alzheimer's disease has eluded scientists despite intense research. The disease is a cause of suffering for millions of people worldwide and is characterized by dementia accompanied by cognitive and motor deficits, ultimately culminating in the death of the patient. The course of the disease progression has various underlying contributing pathways, with the first and foremost factor being the development and accumulation of aberrant and misfolded proteins exhibiting neurotoxic functions. The impairment of cellular clearance mechanisms adds to their accumulation, resulting in neuronal death. This is where the PROteolysis TArgeting Chimera (PROTAC) technology comes into play, bringing the UPS degradation machinery in the proximity of the target protein for initiating its degradation and clearing abnormal protein debris with unparalleled precision demonstrating an edge over traditional protein inhibitors in many respects. The technology is widely explored in cancer research and utilized in the treatment of various tumors and malignancies, and is now being applied in treating AD. This review explores the application of PROTAC technology in developing lead compounds for managing this deadly disease along with detailing the pieces of evidence justifying its utility and efficacy.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11064-022-03722-w

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 100 · Cited by 22

Metadata

Authors
Bhatia, S., Singh, M., Singh, T., & Singh, V.
Affiliations
  • Chitkara University (IN)
  • Texas A&M Health Science Center (US)
Corresponding author
  • Singh, Manjinder
  • Singh, Varinder
Venue
Neurochemical Research
Published
2022-08-20
Volume
48
Issue
1
Pages
13-25
ISSN
  • 0364-3190 (ISSN-L)
  • 1573-6903
OpenAlex
W4292444107
Cited by
22
References
100
Citations by year
2026: 4 · 2025: 5 · 2024: 6 · 2023: 7
FWCI
0.47
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Neurochemical Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords
PROTACs, Alzheimer's disease, protein degradation, ubiquitin-proteasome system, protein clearance, misfolded protein accumulation, neurotoxicity, lead compound development
MeSH terms
Proteolysis Targeting Chimera, Alzheimer Disease, Humans, Neoplasms, Proteins, Ubiquitin-Protein Ligases, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer’s Disease. https://app.cochat.ai/papers/10.1007/s11064-022-03722-w
The paper
Bhatia, S., Singh, M., Singh, T., & Singh, V. (2023). Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer’s Disease. Neurochemical Research. https://doi.org/10.1007/s11064-022-03722-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.